AKAM
42
7
GS
62
14
DLTR
43
3
EXR
46
16
HBAN
62
3
EA
65
5
BSX
68
2
HST
34
2
CCL
57
6
EIX
48
3
HAS
44
2
ECL
45
-2
DFS
42
-18
CNX
55
2
APD
47
3
IFF
50
8
CF
44
3
DGX
62
5
CAG
55
2
DG
40
2
AKAM
42
7
GS
62
14
DLTR
43
3
EXR
46
16
HBAN
62
3
EA
65
5
BSX
68
2
HST
34
2
CCL
57
6
EIX
48
3
HAS
44
2
ECL
45
-2
DFS
42
-18
CNX
55
2
APD
47
3
IFF
50
8
CF
44
3
DGX
62
5
CAG
55
2
DG
40
2
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

Your Data Made Them Billions-Now It's Your Turn to Profit

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
$54.81
Seasonality Move:
5.18%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 26.1% based on the past 14 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 8 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $54.71. The Score for BIB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 26.1% based on the past 14 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
47
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 8 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
47.20

Prediction Charts

Market Cap:
0
Price in USD:
54.71
Volume:
3.9K
Beta:
1.83

Technical Analysis

SMA50:
53.88
SMA100:
56.31
SMA200:
59.58
52-Wk Change:
-2.37%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 54.71 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-25 56.41 55.50 56.41 54.72
Feb-26 55.38 54.86 56.16 54.37
Feb-27 55.07 53.63 55.53 53.63
Feb-28 53.11 55.00 55.00 53.11
Mar-3 54.56 52.86 55.25 52.35
Mar-4 52.38 53.17 53.90 51.78
Mar-5 52.73 54.98 55.17 52.73
Mar-6 54.13 54.27 54.27 53.67
Mar-7 54.21 54.60 55.56 53.84
Mar-11 53.68 53.00 53.68 51.50
Mar-12 52.80 53.29 53.64 52.52
Mar-13 53.94 52.57 53.94 52.38
Mar-14 53.10 53.17 53.62 52.68
Mar-17 53.09 54.71 54.85 53.07

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.